BCAX Operating Expenses

Bicara Therapeutics Inc · Operating Expenses

BCAX logo

BCAX Operating Expenses

Latest reported$201.99M
BCAX TTM Operating Expenses ($39.89M → $201.99M)
High-resolution chart · PNG

BCAX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bicara Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
201,991,000
174,058,000
155,604,000
141,119,000
121,071,000
108,803,000
82,389,000
69,439,000
58,341,000
46,927,000
39,889,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.